Arufen

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Arufen

Arufen is a medicinal product containing the active ingredient Ibuprofen, a widely utilized substance globally recognized as a Nonsteroidal Anti-inflammatory Drug (NSAID). This classification identifies it as an agent that relieves pain and reduces inflammation and fever by interfering with specific biological processes. Arufen is a single-ingredient product, whose therapeutic action derives solely from the activity of Ibuprofen.


Property Description
Active ingredient Ibuprofen (INN)
Form Tablets, oral suspension, gels, creams, suppositories
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Symptomatic relief of pain, inflammation, and fever
Origin Synthetic compound (Propionic acid derivative)

What is Arufen and Its Pharmacological Class?

Arufen is fundamentally a trade name for the substance Ibuprofen. The active compound is chemically defined as a propionic acid derivative, placing it firmly within the NSAID group, which originated from research seeking a safer alternative to earlier analgesics. Ibuprofen is utilized for its efficacy in reducing pain and fever across diverse patient groups. Ibuprofen is indicated for the symptomatic treatment of mild to moderate pain, inflammation, and fever.

Composition and Available Forms of Arufen

The composition of Arufen is based on the Ibuprofen molecule combined with standard pharmaceutical excipients necessary for its delivery. The product is formulated for both systemic (oral and rectal) and local (topical) administration. Characterized by a rapid onset of action following oral ingestion, Ibuprofen is distinguished from various other NSAIDs. Arufen is available across several common dosage forms, including oral preparations such as tablets and oral suspension, as well as topical preparations like gels or creams, allowing for flexible application based on the therapeutic need.

General Purpose: What Does Arufen Help Relieve?

The general therapeutic purpose of Arufen is to offer effective symptomatic relief across three major domains: analgesia (pain relief), anti-inflammation (reduction of swelling and redness), and antipyresis (fever reduction). This triple-action profile makes it suitable for common discomforts, such as the aches and stiffness that accompany mild inflammatory conditions. By acting to interrupt the synthesis of chemical mediators (prostaglandins) that trigger these physiological responses, Arufen supports the body's comfort during periods of acute pain or inflammation.

Regulatory References

  1. Ibuprofen - StatPearls - NCBI Bookshelf - NIH

What side effects are possible with Arufen?

Arufen contains Ibuprofen, a Nonsteroidal Anti-inflammatory Drug (NSAID), and its safety profile reflects risks documented by government regulatory agencies (e.g., FDA, EMA).

Adverse Reactions by System and Frequency

Official labeling classifies adverse reactions based on the body system affected and their reported frequency. Common effects frequently involve the Gastrointestinal System, including dyspepsia, heartburn, nausea, vomiting, abdominal pain, diarrhea, and constipation. Neurological effects such as headache and dizziness are also common. Uncommon reactions include hypersensitivity events like skin rash.

Serious Adverse Reactions

Regulatory warnings highlight the potential for serious, life-threatening events associated with the NSAID class. These include:

  • Serious Cardiovascular Thrombotic Events: Increased risk of myocardial infarction (heart attack) and stroke, which can occur early in treatment and may increase with duration of use.
  • Serious Gastrointestinal Events: Increased risk of bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal and may occur without warning symptoms. The risk is higher for those with a history of such events and the elderly.
  • Severe Cutaneous Reactions: Rare but severe allergic and skin reactions, such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), are documented.

Population-Specific Safety Considerations

Safety statements include restrictions for specific populations:

  • Older Adults (Age 60+): This group has a significantly increased risk of serious gastrointestinal adverse events.
  • Pregnancy: Use of NSAIDs is generally not recommended after 20 weeks of pregnancy and is specifically contraindicated from the third trimester (30 weeks onward) due to the documented risk of fetal renal dysfunction and premature closure of the fetal ductus arteriosus.

Safety-Related Restrictions

Official labeling defines restrictions, including that Arufen is generally contraindicated in patients with a history of severe gastrointestinal bleeding or peptic ulcers, and those with severe, uncontrolled heart, renal, or hepatic failure. The risk of serious cardiovascular and GI events is documented to increase with longer duration of use and higher dosage.

Overdose and Emergency Response

Overdose and When to Seek Help

Regulatory documents mandate that individuals seek immediate medical attention or contact a Poison Control Center if an Arufen (Ibuprofen) overdose is suspected, even if symptoms are not apparent. Exposure to supratherapeutic amounts requires prompt emergency action.

Documented Overdose Manifestations

Official labeling documents symptoms that commonly accompany an overdose:

  • Gastrointestinal Effects: Abdominal pain, nausea, vomiting, diarrhoea, and heartburn.
  • Central Nervous System (CNS) Effects: Drowsiness, headache, dizziness, and ringing in the ears (tinnitus).

Severe Outcomes and Required Management

Overdose has the potential for severe or life-threatening outcomes, primarily affecting the gastrointestinal, renal, and CNS systems. Documented severe manifestations include gastrointestinal bleeding, acute kidney failure, metabolic acidosis, hypotension, and convulsions.

No specific antidote is known for Ibuprofen. Treatment is strictly symptomatic and supportive, and may include procedures such as administering activated charcoal and monitoring vital signs in a hospital setting. Regulatory information notes that dehydrated children and the elderly are specific populations with an increased risk of severe adverse reactions during overdose.

Therapeutic Uses of Arufen

Arufen is used across therapeutic domains involving certain distressing symptoms, generally used for managing symptoms related to pain, inflammation, and fever. It is commonly applied in clinical settings that involve acute or unstable symptom patterns, supports patients during difficult episodes by easing distress.

The medication is applied in addressing conditions marked by increased physiological stress and is relevant when supportive symptom management is appropriate.


Symptomatic Relief Domains

Arufen is commonly used across conditions presenting with acute episodes of pain, helping address groups of symptoms that interfere with daily functioning, focusing on mild to moderate pain levels. Indications include managing recurrent or episodic manifestations like headaches, toothaches, backaches, muscular aches, and menstrual cramps (primary dysmenorrhea). It is also relevant in contexts involving inflammatory or irritative states associated with conditions such as osteoarthritis and rheumatoid arthritis, and is relevant for easing fever during colds and flu.


Key Therapeutic Benefit

This application offers supportive relief when symptoms interfere with routine activities, contributes to improved comfort during symptomatic periods, and assists with maintaining functional stability. By addressing symptoms related to physical discomfort and systemic imbalance, Arufen supports patients during episodes of heightened discomfort.

Quick Fact: Focus on easing Joint Stiffness and Fever symptoms

Regulatory References

  1. NIH MedlinePlus overview on Ibuprofen

Eligibility and Restrictions for Use

Who can and cannot use Arufen?

Regulatory documents define eligibility for Arufen based on specific population groups and pre-existing medical conditions.


Contraindications (Must Not Use)

Use of Arufen is contraindicated in several specific populations, including:

  • Patients with known hypersensitivity to Ibuprofen or any other Nonsteroidal Anti-inflammatory Drug (NSAID), including aspirin.
  • Patients with active, or history of recurrent, peptic ulceration or gastrointestinal haemorrhage.
  • Individuals with severe heart failure, severe hepatic failure, or severe renal failure.
  • Women who are in the third trimester of pregnancy (after 30 weeks' gestation).
  • Patients requiring treatment for peri-operative pain after Coronary Artery Bypass Graft (CABG) surgery.

Eligibility and Restrictions

  • Age-Related Rules: Arufen is generally permitted for adults and adolescents. Children 6 months of age and older are eligible for appropriate formulations, but use is not established for infants younger than 6 months. Elderly patients (ge 60 years) require special caution due to increased risk.
  • Conditional Use: The medicine must be used with careful consideration by patients with uncontrolled hypertension, pre-existing cardiovascular disease, or mild-to-moderate organ impairment.
  • Pregnancy/Lactation: Use is contraindicated in the third trimester and avoided earlier in pregnancy. Arufen is generally considered compatible with breastfeeding as only trace amounts enter human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes the clinically significant interactions for Arufen as documented in official government labeling. The interaction profile is structured to identify constraints related to co-administered medicines that may alter the drug’s effects.

Interaction Classifications

Classification Relevance Defined in Official Documents
Pharmacodynamic Potential for increased bleeding due to interference with thrombocyte aggregation, as documented with other nonsteroidal anti-inflammatory drugs.
Drug-Drug Specific Ineffectiveness of co-administered acetylcholine chloride and carbachol has been reported in patients treated with the ophthalmic solution.
Use in Specific Conditions Caution is recommended when used in surgical patients with known bleeding tendencies or those receiving other medications that may prolong bleeding time.

Official Interaction Statements

  • The interaction of the ophthalmic solution with other topical ophthalmic medications has not been fully investigated.
  • Although formal studies with acetylcholine chloride and carbachol revealed no interference, and no pharmacological basis for an interaction is known, regulatory reports exist that these medicines have been ineffective when used concomitantly.

Connection to the overall interaction profile: Official regulatory documents establish that clinically significant interactions, whether observed or predicted, must be documented. For this product, constraints are primarily defined by the potential for pharmacodynamic effects on hemostasis and observed clinical reports of reduced effectiveness of specific ophthalmic agents when co-administered.

Mechanism of Action

How Arufen Works at the Cellular Level

Arufen's mechanism centers on the irreversible inhibition of the enzyme thioredoxin reductase ( TrxR), a critical component of the cellular antioxidant system. This targeted inhibition disrupts the cell's ability to manage its redox balance, which then triggers a cascade that modulates key inflammatory pathways. The drug's action is defined by two primary mechanistic domains.


Regulation of Inflammatory Gene Transcription

Interfering with the factors' nuclear entry reduces the transcription of genes for inflammatory mediators, such as cytokines and chemokines. This mechanistic domain results in decreased levels of inflammatory mediators following the interference with pro-inflammatory transcription factors, such as NF-kappa B.


️ Moderation of Immune Cell Activity

The shift in the cellular redox balance resulting from TrxR inhibition selectively affects certain immune cell populations. This stress activates apoptotic pathways, leading to the controlled, programmed death of specific hyperactive cells. This domain facilitates the removal of hyperactive immune cells and contributes to the moderation of the immune system's overall activity.

Dosage and Administration Information

Arufen administration is determined by regulatory guidelines that establish the procedural framework for its use, distinguishing between over-the-counter (OTC) and prescription regimens. The officially approved routes of administration include oral (tablets, capsules, and suspension) and, for specific hospital settings, Intravenous (IV) solution. The primary principle governing use is adherence to the lowest effective dose for the shortest duration necessary to achieve symptomatic control.

The standard adult dosing schedule for OTC symptomatic relief typically involves single doses of 200 mg to 400 mg, with the maximum daily dose restricted to 1200 mg in a 24-hour period. For prescription management of chronic inflammatory conditions, the total daily dose is higher, ranging from 1200 mg to 3200 mg, which is administered in divided doses throughout the day. A mandatory minimum interval of four to six hours must separate individual doses across both regimens.

Regarding administration conditions, oral tablets are required to be swallowed whole without being crushed or chewed to maintain their delivery profile. To minimize gastric irritation, official guidelines note that the medicine may be taken with food or milk. For pediatric administration, dosing is strictly governed by weight-based calculations (mg/kg), necessitating the use of a calibrated measuring device for accurate liquid delivery. Furthermore, the IV form is not given as a bolus but must be prepared and delivered as an infusion over a minimum of 10 to 30 minutes. These requirements establish the standardized protocol for the drug's proper use.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Arufen

Evidence for Use in Acute Pain Relief (Analgesia)

Studies examined the compound in research exploring how symptoms change over time during acute, short-term episodes. Research has primarily involved short-term, randomized controlled trials (RCTs) and meta-analyses that explored how symptoms evolved in adult and pediatric populations. These studies often focus on conditions associated with acute or disruptive episodes, such as headache, dental pain, and pain following surgical or accidental musculoskeletal injuries.

The main outcomes monitored in these trials included changes in validated pain intensity scores reported by patients, tracking the time to perceived relief, and recording the proportion of participants who needed rescue pain medication. Studies monitored changes in discomfort scores. Findings describe patterns observed in the hours immediately following administration in the observed populations.

Evidence for Use in Chronic Musculoskeletal Symptoms

Studies examined the compound in the context of conditions characterized by functional limitations and periods of heightened symptoms, such as chronic joint pain related to osteoarthritis. Research in this area includes intermediate-term RCTs and long-term observational settings evaluating daily-life functioning in adult and older adult populations.

The key limitation is that follow-up durations were limited in many controlled trials, which means insight into sustained maintenance outcomes over many years is primarily derived from observational studies, where certainty remains low. Evidence quality varies across studies.

Evidence for Use in Fever Reduction (Antipyresis)

Studies examined the compound for outcomes monitoring physiological strain or stress in adult and pediatric populations experiencing fever. Research has explored short-term symptom changes using RCTs and systematic reviews.

In these trials, researchers primarily monitored specific outcomes related to temperature, such as the change in body temperature from baseline and the duration of the fever-free period. Research reports patterns where a decline in body temperature was measured in the hours following administration. Research describing antipyresis in children has been widely conducted.


Research Gaps and Areas of Uncertainty

A review of the evidence highlights several limitations. Comparative evidence is lacking for certain new or low-prevalence acute pain models. For chronic conditions, follow-up durations were limited in many controlled trials. Additionally, evidence quality varies across studies, particularly when comparing different formulations.

The research provides context but not individual predictions. Studies contribute to understanding symptom patterns by highlighting what is known and what is still uncertain about the compound's performance under specific research conditions.

Frequently Asked Questions (FAQ)

Common questions about Arufen (FAQ)


Q: Is Arufen considered safe for long-term use?

Official regulatory documents caution that the risk of serious side effects, especially cardiovascular events (like heart attack or stroke) and gastrointestinal bleeding, is documented to increase with longer duration of use and higher doses. Regulatory documents describe the use of Arufen as generally adhering to the lowest effective dose for the shortest amount of time necessary to control symptoms.


Q: What is the typical duration of treatment with Arufen for the condition it treats?

Regulatory guidance often describes taking Arufen for the shortest necessary time. For self-treating minor pain or fever with the over-the-counter dose, use is typically limited to no more than 3 to 10 days, unless a healthcare professional provides supervision for use beyond those limits.


Q: What are the key findings or themes from the research evidence about Arufen?

Research themes consistently describe Arufen's action in providing symptomatic relief for pain and fever. Studies, such as short-term randomized controlled trials, typically monitor outcomes like a reduction in validated pain intensity scores and a decline in body temperature, highlighting the medicine's role in short-term symptom management.


Q: Is Arufen safe to drink alcohol while taking Arufen?

Regulatory guidance suggests limiting or avoiding alcohol consumption while taking Arufen. Drinking alcohol while using this medicine can potentially increase the risk of certain side effects, such as gastrointestinal irritation or bleeding, and may also increase dizziness or fatigue.


Q: Is it normal to feel a change in my symptoms right after starting Arufen?

Yes, official pharmacological data indicates that the pain-relieving effects of Arufen generally begin within 20 to 30 minutes after taking an oral dose. Maximum relief is often reported to occur within one to two hours, consistent with its intended rapid onset of action for pain and fever.


Q: Can Arufen affect my ability to drive or operate machinery?

Official labeling notes that Arufen can cause central nervous system side effects such as dizziness or feeling tired. Official labeling states that caution is warranted regarding driving or operating machinery until the individual's response to the medicine is understood.


Q: Can Arufen interact with over-the-counter (OTC) pain relievers like ibuprofen or acetaminophen?

Arufen contains the active ingredient ibuprofen, which is a Nonsteroidal Anti-inflammatory Drug (NSAID). Official warnings document the need to avoid taking Arufen with any other product containing ibuprofen or other NSAIDs (like naproxen) due to the significantly increased risk of serious side effects, such as stomach bleeding.


Q: How quickly should I expect to feel the effects of Arufen?

Studies on the active ingredient indicate that the onset of pain relief generally begins within 20 to 30 minutes after oral administration. This indicates that relief is often measured shortly after administration.


Q: What happens if I stop taking Arufen suddenly?

Arufen is a Nonsteroidal Anti-inflammatory Drug (NSAID) and is not associated with dependence or addiction, according to authoritative sources. For short-term use, stopping the medicine suddenly is generally not associated with physical withdrawal effects.


Q: Are there any common foods or drinks that should be avoided while taking Arufen?

Regulatory documents primarily mention that the medicine may be taken with food or milk to minimize gastric irritation, and caution is advised regarding alcohol use. No specific common food interactions or absolute food prohibitions are routinely listed in official labeling.


Q: What is the difference between the brand name Arufen and its generic version?

The active ingredient, ibuprofen, is the same in both the brand name Arufen and its generic versions. Regulatory agencies require that generic drugs meet the same high standards for strength, quality, and effectiveness as the branded product. Differences typically exist in inactive ingredients, cost, and appearance.


Q: Does Arufen affect blood pressure or heart rate?

Official warnings note that Arufen may cause an increase in blood pressure and may cause or worsen high blood pressure. Regulatory documents indicate that use by patients with pre-existing cardiovascular conditions, including hypertension, warrants careful consideration.


Q: Is Arufen an addictive or habit-forming medicine?

No, Arufen is a Nonsteroidal Anti-inflammatory Drug (NSAID) and is not classified as an addictive or habit-forming medicine according to official drug descriptions and regulatory classifications.


Q: Can Arufen be taken during pregnancy or while breastfeeding?

Use of Arufen is not recommended after 20 weeks of pregnancy and is specifically contraindicated from the third trimester (after 30 weeks). However, only trace amounts of the active ingredient are typically found in breast milk, and it is generally considered compatible with breastfeeding by official bodies.


Q: Are the side effects of Arufen temporary or do they usually last a long time?

Common side effects like mild gastrointestinal upset, headache, or dizziness are usually temporary and often subside when the medicine is stopped or the body adjusts. However, the risk of serious side effects, such as cardiovascular or gastrointestinal harm, is linked to higher doses and longer durations of use.


Q: What should I do if I miss a dose of Arufen (general information)?

General instructions for a missed dose state that the dose may be taken when needed for pain relief, maintaining adherence to the required minimum dosing interval. Regulatory documents define that taking two doses together to compensate for a missed dose is avoided.


Q: Does Arufen have any known interactions with birth control pills?

Official interaction databases for the active ingredient, ibuprofen, do not typically list a known interaction with most common hormonal birth control pills (oral contraceptives). However, official documents describe the need for awareness of co-administered medicines.


Q: Is Arufen associated with any specific mood changes or mental health side effects?

While common side effects include neurological effects like dizziness or headache, specific listings for mood changes or mental health side effects like severe depression or anxiety are not routinely cited in the most common sections of official regulatory labels.


Q: Why do some people need a lower dose of Arufen than others?

Official dosing guidelines are based on the principle of using the lowest effective dose to minimize risk. Doses vary depending on the condition being treated (e.g., pain vs. chronic inflammation) and may be calculated based on weight for pediatric patients or adjusted for older adults or patients with specific health conditions.


Q: Is there a maximum time someone can stay on Arufen according to official documents?

For over-the-counter use, official guidelines typically restrict use to a maximum of 3 days for fever and 10 days for pain, unless a healthcare professional provides supervision for use beyond those limits.


Q: Are allergic reactions to Arufen common, and what are the signs?

Official labeling states that allergic reactions can occur, especially in people allergic to aspirin or other NSAIDs. Signs of a severe allergic reaction may include hives, facial swelling, asthma (wheezing), shock, skin reddening, rash, and blisters.


Q: What is the purpose of the different strengths/dosages of Arufen mentioned in official labeling?

Different available strengths (such as 200 mg or 800 mg) are used to manage different therapeutic goals. Lower strengths are generally intended for over-the-counter pain and fever relief, while higher prescription strengths are used for managing chronic inflammatory conditions under professional supervision.


Q: Is Arufen effective for everyone who takes it, based on official studies?

Clinical studies describe patterns where the medicine is generally effective in reducing symptoms in observed populations, which contributes to its official indications. However, as with all medicines, the effects are not guaranteed to be the same for every individual patient who takes it.


Q: Does Arufen interact with any common medications for depression or anxiety?

Official warnings list potential interactions with certain types of antidepressants (e.g., SSRIs), which may increase the risk of gastrointestinal bleeding when used at the same time as Arufen. Official documents describe the need for awareness of co-administered medicines.


Q: What are the official sources of information about Arufen's safety and effectiveness?

Factual information about Arufen's safety, effectiveness, and regulatory status is primarily derived from official documentation published by government bodies. These include drug agencies such as the FDA, the EMA, Health Canada, and the NIH (MedlinePlus).


Q: Does the time of day I take Arufen matter for its effectiveness?

The official dosing schedule requires a minimum interval (usually four to six hours) between doses to maintain a steady and non-toxic level in the body. The specific time of day is generally not a factor in its effectiveness, provided the required interval is respected.


Q: Is it safe to take Arufen if I am also taking a blood thinner?

Official documents state that taking Arufen with anticoagulants or blood thinners can lead to an increased risk of serious bleeding events due to the active ingredient's effect on blood clotting. Official labeling documents that the co-administration of these medicines warrants careful consideration due to the risk of bleeding.


Q: Are there different forms of Arufen (e.g., tablet, liquid, injection)?

Yes, Arufen is available in multiple formulations to suit different administration needs. These forms include oral tablets, capsules, and oral suspension, as well as topical preparations like gels or creams, and an Intravenous (IV) solution for use in specific healthcare settings.


Q: Does Arufen cause problems if I'm exposed to a lot of sun?

The active ingredient, ibuprofen, is listed in official literature as a medicine that can occasionally cause an abnormal skin response to ultraviolet (UV) rays, known as photosensitivity (increased sun sensitivity). Patients should be aware of this potential effect.


Q: Can Arufen affect my blood sugar levels?

Official research notes that the active ingredient may occasionally affect plasma glucose levels or increase the risk of hypoglycemia (low blood sugar), particularly in diabetic patients who are taking other specific anti-diabetic medications.


Q: Are there any known long-term side effects associated with Arufen use?

Regulatory warnings highlight the potential for serious cardiovascular thrombotic events (like heart attack or stroke) and serious gastrointestinal events (like bleeding or perforation). The risk of these events is documented to increase with long-term use, especially at high doses.

How should Arufen be stored and disposed of?

Arufen (Ibuprofen) must be stored and disposed of in strict accordance with official regulatory labeling to ensure product stability and safety.

Storage Conditions

Requirement Official Mandate
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F).
Environment Protect from moisture and excessive heat; do not freeze.
Container Keep in the original container, tightly closed.
Child Safety Keep out of the sight and reach of children.

Disposal Instructions

Discard any unused or expired Arufen strictly according to local regulations. The medicine should generally not be disposed of via household waste or wastewater unless specifically advised by official guidance or a take-back program. Do not use the product after the expiration date.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Arufen found in:

A-Z Index: